TMS Co., Ltd. (TYO:4891)
Japan · Delayed Price · Currency is JPY 146.00
-2.00 (-1.35%)
May 12, 2026, 3:30 PM JST
TMS Co., Ltd. Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
6.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Feb 28, 2025 | - | - | - |
| Feb 29, 2024 | - | - | - |
| Feb 28, 2023 | - | - | - |
| Feb 28, 2022 | 1.95B | - | - |
| Feb 28, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kohjin Bio | 5.07B |
| Soiken Holdings | 4.58B |
| CellSource | 3.72B |
| StemCell Institute | 2.78B |
| MEDINET | 998.00M |
| OncoTherapy Science | 808.00M |
| PRISM BioLab Co.,LTD | 684.61M |
| Chiome Bioscience | 593.29M |